Insider: Watson David O. General Counsel - Apellis Pharmaceuticals, Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 88,531 | 50,136 | 138,667 |
| Value | $3,575,767.09 | $2,024,993.04 | $5,600,760.13 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 01/22/2026 | DDS | 7,832 | Direct | COM | $21.77 | $170,466.61 | 88,531 |
| 01/20/2026 | DDS | 2,475 | Direct | COM | $19.79 | $48,987.43 | 96,363 |
| 01/13/2026 | DDS | 5,780 | Direct | COM | $22.19 | $128,242.02 | 98,838 |
| 12/16/2025 | DDS | 5,000 | Direct | COM | $24.49 | $122,450.00 | 103,730 |
| 11/17/2025 | DDS | 5,000 | Direct | COM | $20.06 | $100,300.00 | 108,730 |
| 10/16/2025 | DDS | 5,000 | Direct | COM | $25.22 | $126,100.00 | 113,730 |
| 09/16/2025 | DDS | 5,000 | Direct | COM | $24.34 | $121,700.00 | 118,730 |
| 09/10/2025 | DDS | 20,000 | Indirect | COM | $26.17 | $523,400.00 | 50,136 |
| 08/18/2025 | DDS | 5,000 | Direct | COM | $27.80 | $139,000.00 | 123,730 |
| 07/16/2025 | DDS | 5,000 | Direct | COM | $19.55 | $97,750.00 | 128,730 |
| 06/16/2025 | DDS | 5,000 | Direct | COM | $18.77 | $93,850.00 | 133,730 |
| 03/05/2025 | DDS | 5,569 | Direct | COM | $25.10 | $139,789.14 | 138,730 |
| 01/29/2025 | DDS | 695 | Direct | COM | $29.52 | $20,518.90 | 144,299 |
| 01/22/2025 | DDS | 3,323 | Direct | COM | $30.43 | $101,103.94 | 144,994 |
| 01/17/2025 | DDS | 2,201 | Direct | COM | $29.96 | $65,938.00 | 105,555 |
| 01/13/2025 | DDS | 4,965 | Direct | COM | $28.70 | $142,505.93 | 107,756 |
| 12/11/2024 | DDS | 5,000 | Direct | COM | $34.24 | $171,175.00 | 112,721 |
| 02/12/2024 | DDS | 781 | Direct | COM | $67.77 | $52,925.95 | 103,390 |
| 01/29/2024 | DDS | 906 | Direct | COM | $64.14 | $58,109.21 | 104,171 |
| 01/22/2024 | DDS | 4,184 | Direct | COM | $65.00 | $271,943.26 | 105,077 |
| 01/16/2024 | DDS | 4,240 | Direct | COM | $66.81 | $283,268.46 | 109,261 |
| 12/19/2023 | DDS | 1,605 | Direct | COM | $57.00 | $91,491.58 | 92,053 |
| 12/19/2023 | DDS | 2,300 | Direct | COM | $57.38 | $131,980.21 | 89,753 |
| 06/22/2022 | DDS | 10,000 | Direct | COM | $44.51 | $445,140.00 | 115,569 |
| 04/25/2022 | DDS | 5,000 | Direct | COM | $50.00 | $250,000.00 | 125,569 |
| 1 2 Next Last You are at page 1 of 2 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2026 Zacks Investment Research